1Joseph T, Santoso, Leslie Evans, et al. Deep venous throm- bosis in gynecological ontology: Incidence and clinical symp- toms study[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009, 14: 173.
8Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease : the seventh ACCP conference on antithrombotic and thrombolytic therapy [ J ]. Chest, 2004, 126 (3 Suppl) :401S.
9Augustions P, Ouriel K. Invasive approaches to treatment of venous thromboembolism [ J ]. Circulation,2004,110 (9) :27-34.
10Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the RISTOS project [ J]. Ann Surg, 2006,243 (1) :89-95.
4Samama M M. A silent killer: exploring the burden of VTE in medical patients. In: VTE Experts Meeting[ J ]. Belgium, 2004, 51.
5Elsharawy M, Elzayat E. Early results of thrombolysis vs an- ticoagulation in iliofemoral venous thrombosis. A randomised clinical trial[J]. Eur J Vasc Endovasc Surg, 2002, 24(3) : 209.
7Wun T,White RH.Epidemiology of cancer-related venous thromboem- bolism[J]. Bailliere's Best Practice and Research Clinical Haematology, 2009,22(1):9-23.
8Lyrnan GH,Khorana AA,Falanga A,et al.American Soci-ety of Clinical Oncology guideline:recommendations for ve-nous thromboembolism pro- phylaxis and treatment in pa-tients with cancer[J]. Journal of Clinical Oncology,2007,25(34):5490-5505.
9Greer Ian A,Nelson-Piercy Catherine.Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood . 2005
